Parkwood LLC Legend Biotech Corp Transaction History

Parkwood LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$39.5 - $57.22 $12,324 - $17,852	-312 Reduced 2.3%	13,250 $587,000
Q1 2024 May 15, 2024	BUY	$55.06 - $69.99 $37,330 - $47,453	678 Added 5.26%	13,562 $761,000
Q4 2023 Feb 14, 2024	SELL	$57.25 - $69.74 $39,101 - $47,632	-683 Reduced 5.03%	12,884 $775,000
Q3 2023 Nov 14, 2023	BUY	$63.16 - $76.5 $573,998 - $695,232	9,088 Added 202.9%	13,567 $911,000
Q2 2023 Aug 14, 2023	BUY	$46.28 - $75.01 $207,288 - $335,969	4,479 New	4,479 $309,000

225

74.3M

279K

350K

Ticker LEGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 167,403,008
Market Cap $5.49B
Description
Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...

Get notified when there are updates to the investment portfolio of Parkwood LLC, based on Form 13F filings with the SEC.

Stay updated on Parkwood LLC with notifications on news.